2014

Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences

BOULDER, Colo., Feb. 18, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the RBC Capital Markets Global Healthcare and Cowen Annual Healthcare Conferences.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.   

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Event:               

RBC Capital Markets Global Healthcare Conference

Date:                 

Tuesday, February 25, 2014

Time:                 

10:30 a.m. Eastern Time

Location:            

New York Palace Hotel, NYC



Event:                 

Cowen Annual Healthcare Conference

Date:                   

Wednesday, March 5, 2014

Time:                   

9:20 a.m. Eastern Time

Location:              

Marriott Copley Place Hotel, Boston



Webcasts:             

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis).  For more information on Array, please go to www.arraybiopharma.com

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

SOURCE Array BioPharma



RELATED LINKS
http://www.arraybiopharma.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.